Pfizer
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Pfizer (PFE) Business News
Track Pfizer in real time with a live news feed covering Pfizer stock news, official press releases, company announcements, and an archive of historical Pfizer news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Investing $8,000 In Each of These 3 Stocks in 2026 Could Generate $1,500 in Annual Dividends
Build a Six Figure Dividend Stream With Four Blue Chip Names and $2 Million
Four Tickers That Turn $1 Million Into $60,000 of Annual Income
Pfizer (NYSE:PFE) Trading 1.5% Higher Following Analyst Upgrade
My Top 4 Pharma Picks Under Rising Geopolitical Risk
Dividend Harvesting Portfolio Week 267: $26,700 Allocated, $2,927.54 In Projected Dividends
Trellus Health shares jump 39% on Pfizer deal renewal
Apollon Wealth Management LLC Reduces Stock Position in Pfizer Inc. $PFE
Carnegie Investment Counsel Increases Stock Holdings in Pfizer Inc. $PFE
Better Buy Right Now: Johnson & Johnson Vs. Pfizer
Investing $8,000 In Each of These 3 Stocks in 2026 Could Generate $1,500 in Annual Dividends
9:30 AM | Tuesday | Apr 14, 2026
Investing in high-yielding dividend stocks can be risky, but the ones on this list can be gems. These stocks yield between 6.2% and 6.4%.
Read full article
Investing $8,000 In Each of These 3 Stocks in 2026 Could Generate $1,500 in Annual Dividends
The Motley FoolInvesting in high-yielding dividend stocks can be risky, but the ones on this list can be gems. These stocks yield between 6.2% and 6.4%.
Read full article
Build a Six Figure Dividend Stream With Four Blue Chip Names and $2 Million
24/7 Wall StreetTwo million dollars in four household-name dividend payers can generate between $132,000 and $146,000 in annual income.
Read full article
Four Tickers That Turn $1 Million Into $60,000 of Annual Income
24/7 Wall StreetA million dollars sounds like enough to retire on. Whether it actually is depends entirely on what you make it do.
Read full article
Pfizer (NYSE:PFE) Trading 1.5% Higher Following Analyst Upgrade
Defense WorldPfizer Inc. (NYSE: PFE - Get Free Report)'s stock price traded up 1.5% during trading on Monday after UBS Group raised their price target on the stock from $25.00 to $27.00.
UBS Group currently has a neutral rating on the stock. Pfizer traded as high as $27.57 and last traded at $27.3240. 44,069,163 shares were traded
My Top 4 Pharma Picks Under Rising Geopolitical Risk
Seeking AlphaAutoimmune diseases, oncology, and type 2 diabetes continue to spread around the world, but these stocks stay off investors' radars. Many of them consistently beat Street's consensus forecasts and offer dividend yields even higher than oil and gas stocks, as well as the "Magnificent 7." By opening this article, you will find out my "top 4 Big Pharma players."
Read full article
Dividend Harvesting Portfolio Week 267: $26,700 Allocated, $2,927.54 In Projected Dividends
Seeking AlphaThe Dividend Harvesting Portfolio, focused on income and risk mitigation, achieved a 37.41% return on invested capital and $2,927.54 in projected annualized dividend income. Recent macro volatility—oil above $100, elevated CPI, and looming Fed hawkishness—drives caution but creates selective buying opportunities for quality income assets. I added to GPIQ and ARCC, capitalizing on GPIQ's dynamic covered call strategy and ARCC's 9.
43% discount to NAV and 11% yield amid private credit market stress.
Trellus Health shares jump 39% on Pfizer deal renewal
Proactive InvestorsTrellus Health PLC (AIM:TRLS), the digital chronic disease management platform, surged 39% to 0.28p after the company announced it had renewed its licensing agreement with Pfizer. Under the renewed deal, Pfizer will continue to license Trellus Health's patient-support educational content for use in its inflammatory bowel disease (IBD) digital application.
Read full article
Apollon Wealth Management LLC Reduces Stock Position in Pfizer Inc. $PFE
Defense WorldApollon Wealth Management LLC cut its holdings in shares of Pfizer Inc. (NYSE: PFE) by 15.9% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 152,223 shares of the biopharmaceutical company's stock after selling 28,829 shares during the quarter. Apollon Wealth Management
Read full article
Carnegie Investment Counsel Increases Stock Holdings in Pfizer Inc. $PFE
Defense WorldCarnegie Investment Counsel lifted its stake in Pfizer Inc. (NYSE: PFE) by 252.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 154,550 shares of the biopharmaceutical company's stock after purchasing an additional 110,759 shares during the quarter. Carnegie Investment Counsel's holdings
Read full article
Better Buy Right Now: Johnson & Johnson Vs. Pfizer
The Motley FoolJohnson & Johnson is one of the largest pharmaceutical stocks by market cap. Pfizer's dividend offers a hefty yield.
Read full article